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Abstract Brugada syndrome is a hereditary cardiac disease
causing abnormal ST segment elevation in the ECG, right bundle
branch block, ventricular fibrillation and sudden death. In this
study we characterized a new mutation in the SCN5A gene
(T1620M), causing the Brugada syndrome. The mutated
channels were expressed in both Xenopus leavis oocytes and in
mammalian tsA201 cells with and without the L-subunit and
studied using the patch clamp technique. Opposite phenotypes
were observed depending on the expression system. T1620M
mutation led to a faster recovery from inactivation and a shift of
steady-state inactivation to more positive voltages when ex-
pressed in Xenopus oocytes. However, using the mammalian
expression system no effect on steady-state inactivation was
observed, but this mutation led to a slower recovery from
inactivation. Our finding supports the idea that the slower
recovery from inactivation of the cardiac sodium channels seen in
our mammalian expression system could decrease the density of
sodium channels during the cardiac cycle explaining the in vivo
arrhythmogenesis in patients with Brugada syndrome.
z 2000 Federation of European Biochemical Societies.
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1. Introduction
Ventricular ¢brillation is the most common cause of sudden
death, with more than 300 000 deaths per year in the USA
alone [1,2]. Brugada syndrome is a hereditary cardiac disease
characterized by a right bundle-branch block (RBBB), an el-
evation of the ST segment in leads V1 through V3 on the
ECG and a ventricular ¢brillation (VF) that can lead to sud-
den death [3]. The incidence of the Brugada syndrome is
greatest in Asian males. It is a major cause of death in Japan
(6:1000) and much of southeast Asia. The syndrome is a
leading cause of death of young males in Thailand (1:2500)
[4]. The age for the ¢rst arrhythmic event ranges between
2 and 77 years, with a mean age of 35^41 years [4^6]. In
contrast to Long QT syndrome (LQTS), QTc is not a¡ected
in the Brugada syndrome.
Until now, Brugada syndrome has been associated with
only one gene, SCN5A. The gene encodes the K-subunit of
human cardiac voltage-gated sodium channel and is located
on chromosome 3 [7]. In patients with Brugada syndrome,
missense T1620M [8] and R1512W [9], splice-donor, and
frameshift mutations have been identi¢ed in SCN5A [8]. The
insertion of a pair of adenosines disrupts the splice-donor
sequence of intron 7 [10], and the deletion of a single nucleo-
tide (A) at codon 1397 results in an in-frame stop codon that
eliminates DIII/S6, DIV/S1-S6, and the carboxy-terminal por-
tion of the cardiac sodium channel [8]. The T1620M mutation
was expressed and characterized by Chen and coworkers [8] in
Xenopus oocytes. In their study, mutant sodium channel
(T1620M) showed faster recovery from inactivation in com-
parison with the wild-type (WT) cardiac sodium channel and
a shift of the steady-state inactivation curve to more positive
potentials. In particular, unlike SCN5A mutations associated
with long QT syndrome, no persistent inactivation-resistant
currents were observed in the mutated channel [8]. Functional
analysis of the mutant channels have provided a mechanistic
explanation for this elevation of the T-wave in the ECG of
Brugada syndrome patients [11]. It has been suggested [11]
that heterogeneity of repolarization between endocardial and
epicardial layers could be responsible for the clinical manifes-
tation of the Brugada syndrome. In contrast to endocardial
cells, action potentials of epicardial cells display a pronounced
phase 1 due to the transient outward current, Ito, which is
preferentially expressed in the epicardium rather than in the
endocardium of the ventricles of many species, including hu-
mans [12]. This underlies the di¡erence in the endocardial-
epicardial action potential (AP) con¢gurations. Recent studies
also indicate the presence of a much larger transient outward
current Ito in the right versus the left ventricular epicardium
[13] which can explain ECG patterns on the right leads. Per-
turbations in sodium INa and/or transient Ito currents can lead
to a striking abbreviation of the epicardial AP, with the re-
sultant potential for reexcitation due to the epicardial-endo-
cardial heterogeneity of repolarization [14].
In this work, we expressed and characterized the T1620M
mutant cardiac sodium channels in two di¡erent expression
systems, Xenopus oocytes and tsA201 mammalian cells. The
mutant channel showed di¡erent electrophysiological proper-
ties in each system. Our results implicate the electrophysiolog-
ical characteristics of the mutated cardiac sodium channel
hH1/T1620M expressed in mammalian cells as a major cause
of VF and the ST segment elevation in the ECG of Brugada
syndrome patients.
2. Materials and methods
2.1. Mutagenesis
Mutant hH1/T1620M was generated using QuickChange TM site-
directed mutagenesis kit manual instruction from Stratagene (La
Jolla, CA, USA) according to the manufacturer’s instructions. The
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mutations were constructed using the following mutagenic sense and
antisense primers: 5P-GTA CTT CTT CTC CCC GAT GCT CTT
CCG AGT CAT CC-3P and 5P-GGA TGA CTC GGA AGA GCA
TCG GGG AGA AGA AGT AC-3P for hH1/T1620M. The under-
lined nucleotides represent mutated sites.
Mutant and the WT hH1 in pcDNA1 construct were puri¢ed using
Quiagen columns (Quiagen Inc., Chatsworth, CA, USA).
The human sodium channel L1 subunit in pRc/CMV vector was
provided by Dr. A.L. Georges (Vandergilt University, Nashville,
TN, USA).
2.2. Transfections of the tsA201 cell line
The mammalian cell line tsA201 is derived from human embryonic
kidney HEK293 cells by stable transfection with SV40 large T anti-
gen. Cells were grown in high glucose DMEM (Dulbecco’s modi¢ed
Eagle’s medium) supplemented with 10% FBS, L-glutamine (2 mM),
penicillin G (100 U/ml) and streptomycin (10 mg/ml) (Gibco BRL Life
technologies, Burlington, Ont., Canada). Cells were incubated in a 5%
CO2 humidi¢ed atmosphere. The tsA201 cells were transfected using
the calcium phosphate method, with the following modi¢cation: to
better identify the individual transfected cells, 10 Wl of a CD8-a (lym-
phocyte surface antigen) plasmid was cotransfected with 10 Wl of
either the WT or mutant hH1 sodium channels cDNA. For the patch
clamp experiments, 2 to 3 days post-transfection cells were incubated
for 2 min in a medium containing anti-CD8-a coated beads (Dyna-
beads M-450 CD8-a). The unattached beads were removed by wash-
ing. Beads were prepared according to the manufacturer’s instructions
(Dynal A.S., Oslo, Norway). Cells expressing CD8-a on their surface
¢xed the beads and were distinguished from non-transfected cells by
light microscopy.
2.3. Patch clamp methods
Macroscopic sodium currents from transfected cells were recorded
using the whole-cell con¢guration of the patch clamp technique. Patch
electrodes were made from 8161 Corning glass and coated with Syl-
gard (Dow-Corning, Midland, MI, USA) to minimize their capaci-
tance. Low resistance electrodes (6 0.8 M6) were used, and a routine
series resistance compensation of an Axopatch 200 ampli¢er was per-
formed to values s 80% to minimize voltage-clamp errors. Voltage-
clamp command pulses were generated by microcomputer using
pCLAMP software v5.5 (Axon Instruments, Foster City, CA,
USA). Recorded membrane currents were ¢ltered at 5 kHz. Experi-
ments were performed 10 min after obtaining the whole-cell con¢gu-
ration to allow the current to stabilize.
2.4. Solutions and reagents
For whole-cell recording, the patch pipette contained: 35 mM,
NaCl; 105 mM, CsF; 10 mM, EGTA; and 10 mM, Cs^HEPES
(pH 7.4). The bath solution contained: 150 mM NaCl; 2 mM KCl;
1.5 mM CaCl2 ; 1 mM MgCl2 ; 10 mM glucose and 10 mM Na^
HEPES (pH 7.4). A correction of the liquid junction potential of
37 mV between patch pipette and the bath solutions was made. Ex-
periments were performed at ambient temperature (22^23‡C).
2.5. Expression in Xenopus oocytes
Xenopus laevis females were anesthetized with 1.5 mg/ml tricaine
(Sigma), and two or three ovarian lobes were surgically removed.
Follicular cells surrounding the oocytes were removed by incubation
at 22‡C for 2.5 h in calcium-free oocyte medium (82.5 mM NaCl, 2.5
mM KCl, 1 mM MgCl2, 5 mM Na^HEPES, pH 7.6) containing 2 mg/
ml collagenase (Sigma, type 1A). The oocytes were washed ¢rst in
calcium-free medium with a 50% diluted solution of Leibovitz’s L-
15 medium (Gibco) enriched with 15 mM Na^HEPES, 5 mM L-glu-
tamine, and 10 mg/ml gentamicin (pH 7.6); oocytes were stored in this
medium until use. Stage V-VI oocytes were selected and micro-in-
jected with cRNA encoding the WT and the mutant hH1. Oocytes
were used for experiments after 3^5 days.
The macroscopic Nacurrents from cRNA-injected oocytes were
measured by two-microelectrode voltage clamp. The cells were im-
paled with 6 1.5 M6 electrodes containing 3 M KCl and were volt-
age-clamped with an OC-725 Oocyte clamp (Warner Instruments,
Hamden, CT, USA). The Ringer solution bath contained: 116 mM
NaCl; 2 mM KCl; 1.8 mM CaCl2 ; 2 mM MgCl2 ; 5 mM Na^HEPES
(pH 7.6). The holding potential was set between 3110 mV and 380
mV in di¡erent experiments. Data were collected and analyzed using
pCLAMP software v7 (Axon Instruments). The inactivation data
were ¢tted by Boltzmann equation and the recovery data were ¢tted
by exponential function.
2.6. Statistical analysis
Data are expressed as mean þ S.E.M. (standard error of the mean).
When indicated, t-test was performed using statistical software in
SigmaPlot (Jandel Scienti¢c Software, San Rafael, CA, USA). Di¡er-
ences were deemed signi¢cant at a P value 6 0.05.
3. Results
3.1. Expression in Xenopus leavis oocytes
Both mutated (T1620M) and WT cardiac sodium channels
hH1 were expressed and studied in Xenopus oocytes (Fig. 1).
Large sodium currents were recorded from both hH1/WT and
hH1/T1620M mutant channels, indicating that the level of
expression was not a¡ected by the mutation. As can be seen
from Fig. 1 the decay of sodium currents were not a¡ected by
T1620M mutation. The voltage-dependence of the steady-
state inactivation was studied using a two-pulse protocol
and shown to be shifted by nearly 10 mV towards more pos-
itive potentials compared with WT channels (Fig. 2A). The
normalized peak current was ¢tted to a Boltzmann distribu-
tion. The half-inactivation voltages were respectively
367.9 þ 0.6 mV (n = 8) and 377.5 þ 0.8 mV (n = 8) in mutant
T1620M and WT channel. The slope factors were not signi¢-
cantly changed. The T1620M mutation did not induce any
persistent inward currents (data not shown). The recovery
from inactivation was assessed using a double-pulse protocol
and time course of recovery from inactivation was measured.
The time constant of recovery from inactivation was acceler-
ated. For example, time constants of recovery from fast in-
activation measured at 380 mV for T1620M mutant (n = 8)
and the WT (n = 8) channel were 23.5 þ 0.8 ms versus
38.3 þ 1.4 ms, respectively and 7.1 þ 0.2 ms versus 9.3 þ 0.4
ms at 3100 mV (Fig. 2B).
Channels (mutant T1620M and WT) were then coexpressed
with the L regulatory subunit of the cardiac sodium channel
and characterized in Xenopus oocytes. Neither mutated nor
normal channels showed signi¢cant di¡erence in the voltage
dependence of steady-state inactivation when coexpressed
with the L-subunit (Fig. 2A). However, in T1620M mutants,
the inactivation curve was shifted toward a more positive
potentials (with and without the L-subunit). Time constants
of recovery from inactivation were accelerated, for example,
Fig. 1. Representative voltage clamp recording made from oocytes
expression hH1/WT and hH1/T1620M (A) and coexpressed with the
L-subunit (B). Normalized and superimposed current traces were ob-
tained at test potential of 330 mV from a holding potential of
3120 mV are shown.
FEBS 23247 28-1-00
G. Baroudi et al./FEBS Letters 467 (2000) 12^16 13
at holding potential of 380 mV, drec = 19.6 þ 1.9 ms and
30.5 þ 1.2 ms for mutant T1620M and normal channels, re-
spectively (n = 8). The drec from channels coexpressed with the
L-subunit was further accelerated (Fig. 2B).
3.2. Expression in tsA201 cells
Similar experiments were performed in a mammalian ex-
pression system, the tsA201 cell line. First, mutant and nor-
mal channels were expressed separately and studied. Second,
both normal and mutant were coexpressed with the L-subunit.
Elevated currents were recorded from both WT and mutant
channels (Fig. 3). Peak conductance-voltage plots that repre-
sent steady-state activation (Fig. 4A) in mutated hH1/T1620M
channels were indistinguishable from the hH1/WT. Steady-
state inactivation was studied using the double-pulse protocol.
No signi¢cant changes were observed on the steady-state
inactivation curve of the mutant hH1/T1620M channels. In
the presence of the L-subunit, the steady-state inactivation
curves of both hH1/T1620M and hH1/WT were signi¢cantly
shifted by 10 mV toward more positively charged holding
potentials, with no signi¢cant changes in the slope of the
curves (P6 0.05) (Fig. 4A); V1=2 hH1=T1620M =3101.02 þ 1.4
mV (n = 17) compared to V1=2 hH1=WT =3101.06 þ 1.2 mV
(n = 22). However, when recovery from fast inactivation was
studied, T1620M mutant channels, expressed alone or in the
presence of the L regulatory subunit, showed slower recovery
from fast inactivation (Fig. 4B). The mutant hH1/T1620M
alone and hH1/T1620M coexpressed with the L regulatory
subunit were compared to the wild-type hH1/WT and hH1/
WT coexpressed with the L-subunit, respectively. At a holding
potential of 3100 mV, the recovery from fast inactivation was
11.8% slower in cells expressing mutant channels alone than
the WT, and 27.8% slower in cells co-expressing mutants
with the L-subunit compared to the WT coexpressed
with the L-subunit, for example, drec hH1=T1620M = 61.16 þ 3.2
ms (n = 14) vs. drec hH1=WT = 53.96 þ 4.2 ms (n = 22) and
drec hH1=1620ML = 50.87 þ 3.78 ms (n = 12) versus drec hH1=WTL =
36.75 þ 3.8 ms (n = 21). At more negative holding potentials,
mutants showed a signi¢cantly (P6 0.05) slower recovery
from inactivation both in the presence and the absence of
the L-subunit (Fig. 4C).
4. Discussion
In a previous study, Chen et al. identi¢ed a Brugada syn-
drome mutation (T1620M) and its electrophysiological char-
acterization in Xenopus oocytes expression system was re-
ported [8]. They showed that the voltage dependence of the
steady-state inactivation was shifted by nearly 10 mV towards
more positive potentials in T1620M mutated channels com-
pared to the WT channels, with no change in the slope of the
curve. Recovery from inactivation was signi¢cantly faster in
mutated than in WT channels. In this study we compared and
characterized the cardiac sodium channel missense mutation
T1620M after its expression in both Xenopus leavis oocytes
and mammalian tsA201 cells, with and without the L-subunit
Our ¢rst observation was that the expression of the human
cardiac sodium channel was di¡erent in the two experimental
systems tested. In fact, opposite phenotypes were observed
depending upon the expression system. Our results in Xenopus
Fig. 3. Whole-cell sodium current traces from hH1/WT (A), hH1/
WT+L-subunit (B), hH1/T1620M (C) and hH1/T1620M+L-subunit
(D) expressed in the tsA201 cell line. Currents were recorded from a
holding potential of -120 mV stepped from -80 mV to +60 mV dur-
ing 30 ms in 10 mV increments.
Fig. 2. Voltage-dependence of inactivation and time course of recov-
ery from inactivation of hH1 WT and mutants channels expressed
in Xenopus oocytes. A: Voltage-dependence of steady-state inactiva-
tion (hr) of hH1, WT and mutant, at 330 mV triggered by 500 ms
pulse ranged from 3100 mV to 330 mV. The curves were ¢tted to
a Boltzmann distribution I/Imax = 1/1+exp((V3V1=2)/Kv). B: Voltage-
dependence of the time constant of recovery from inactivation.
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oocytes were consistent with those reported by Chen et al. [8].
The steady-state inactivation peak currents in the mutated
channels were shifted by 10 mV toward more positive poten-
tials in comparison to the WT channels in the Xenopus leavis
oocytes system and in both cases (with and without the L-
subunit) ; however, there was no shift in the mammalian ex-
pression system. Recovery from fast inactivation in oocytes
was faster in the case of mutated channels hH1/T1620M
although it showed slower recovery in the mammalian expres-
sion system (tsA201 cells).
Our results also show that coexpression of both channels
(WT and mutant) with the L-subunit further accelerates time
constants of the recovery from fast inactivation. These obser-
vations indicate that the regulatory L-subunit plays an impor-
tant role in modulating the human cardiac sodium channel.
In a recent study, Dumaine and coworkers found that at
room temperature the recovery from fast inactivation was
slightly faster in T1620M mutant than at 32‡C [15]. We ob-
served a slower recovery from inactivation at room temper-
ature and even slower when the L-subunit was present. The
cause of this discrepancy is not clear. We think that working
at a higher temperature should result in qualitatively similar
results (slowing of recovery from inactivation).
This suggests another explanation for the implication of the
cardiac sodium channel in the Brugada syndrome and its
ECG patterns. It could be that the human cardiac sodium
channel protein expressed and studied in a mammalian de-
rived expression system more closely approximates the in
vivo arrhythmic cases given the similarities in the cellular
metabolism and the environmental circumstances between
the human ventricular myocytes and the tsA201 mammalian
cells.
Observations and hypothesis postulated in previous studies
support the idea that the 50% loss of functional cardiac so-
dium channels in the human heart results from the premature
in-frame stop codon in the DIII-S6 region of the human car-
diac sodium channel and that this is the cause of the shorter
duration of the AP in epicardial cells [8]. This shortening is
related to the presence of the transient outward current, Ito,
which is more prominent in epicardial than endocardial my-
ocytes [12]. Also, several reports of the pharmacological ef-
fects of drugs that block the sodium channel have indicated
that treatment with class IA inactivated-state blockers (diso-
pyramide, procainamide, £ecainide and ajmaline) increased
ST-segment elevation [16^18] in patients both with transient
normalized ECGs and in the family members with normal
ECGs. In summary, our data suggest that the characteristi-
cally elevated ST-segment appearing on the ECG of patients
with Brugada syndrome is most probably due to the slower
recovery from inactivation of the cardiac sodium channels.
This can be explained by the presence of the T1620M which
abolishes the opposing current (inward Nacurrent) during
the cardiac cycle in patients carrying this mutation.
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